COVID-19 AND KIDNEY DAMAGE

Main Article Content

Azizova Shoira Kayumovna
Haydarov Sanjar Nizomitdinovich

Abstract

The review provides data on the frequency and causes of the onset and development of acute kidney injury (AKI) in COVID -19. A review of the available scientific information regarding the occurrence and / or progression of chronic kidney disease with covid -19 was carried out, and an emphasis was placed on rare forms of kidney damage that can develop with covid -19. Attention is paid to aspects of etiopathogenesis and the clinical picture of kidney damage in covid -19. The authors, when writing the article, globally did not touch upon the treatment of renal pathology formed during covid -19, since it is currently mainly reduced, on the one hand, to the treatment of a specific form of kidney disease, on the other hand, to the treatment of the coronavirus infection itself. Understanding the processes of alteration of kidney tissue cells in this disease may help in the future to determine approaches to the prevention of kidney damage and the restoration of their function in patients who are ill or have had covid -19.

Article Details

How to Cite
Azizova Shoira Kayumovna, & Haydarov Sanjar Nizomitdinovich. (2022). COVID-19 AND KIDNEY DAMAGE. Galaxy International Interdisciplinary Research Journal, 10(3), 241–245. Retrieved from https://internationaljournals.co.in/index.php/giirj/article/view/1453
Section
Articles

References

Zakharova EV. The role of cyclosporine in the treatment of idiopathic glomerulonephritis and lupus nephritis. Nephrology and dialysis 2010; 12(2): 126-141

Kozlovskaya L.V. Chronic glomerulonephritis: arguments in favor cyclosporine. Clinical Nephrology 2010; 3:56-61

Smirnov A.V. Treatment of glomerulopathies with cyclosporine: the right approach with the wrong rationale. Nephrology 2010; 14(4):9-22

Smirnov A.V. Practical issues of the use of cyclosporine in the treatment glomerulopathies. Nephrology 2010; 14(4):96-102

Komarova O.V., Matveeva M.V., Tsygin A.N., Leonova L.V., Timofeeva A.G. Efficacy and safety of prolonged cyclosporine therapy in children with focal segmental glomerulosclerosis. Questions of modern pediatrics 2010; 9(4): 155-159

Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16(3): CD003233

Abdurakhmanovich, KO, & ugli, GSO (2022). Ultrasonic Diagnosis Methods for Choledocholithiasis. Central Asian Journal Of Medical And Natural Sciences , 3 (2), 43-47. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/619

Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephritic syndrome: workshop recommendations. Kidney Int 2007; 72(12): 1429-1447

. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56(6): 2220-2226

Chun MJ, Korbet SM, Schwartz MM et al. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004; 8:2169–2177.

Abdurakhmanovich, KO, & ugli, GSO (2022). Ultrasound Diagnosis of the Norm and Diseases of the Cervix. Central Asian Journal Of Medical And Natural Sciences, 3(2), 58-63. Retrieved from https://cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/622